1Gurnery K A, Cartwright R A, Gilman E A, et al. Descripitive epideiniology of gastrointestinal Non-Hodgkin' s lymphoma in a population based registry [ J ]. Br J Cancer, 1999, 79 ( 11 - 12): 1929 - 1934.
4Dogusoy G, Karayel F A, Gocener S, et al. Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas[J]. Pathol Oncol Res, 1999, 5(1): 36 -40.
5Issacson P G. Gastric MALT lymphoma: from concept to cure [ J ].Ann Oncol, 1999, 10(6): 637 -645.
6Gakamura T, Inagaki H, Seto M, et al. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration [ J ]. J Gastroenterol, 2003, 38(10): 921 -923.
7Radman I, Kovacevic Metelko J, Aurer I, et al. Surgical resection in the treatment of primary gastrointestinal non-Hodgkin' s lymphoma: retrospective study[J]. Croat Med J, 2002, 43(5): 555 -560.
8Neumeister P, Hoefler G, Beham Schmid C, et al. Complete remission of generalized relapsed extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type of the gastrointestinal tract after high-dose chemotherapy and autologous peripheral stem cell transplantation[J]. Ann Hematol, 2000, 79(12): 703 -735.
5Isaaeson PG, Wright DH. Malisnant lymphoma mueosa associated lymphoid tissue. A distinctive type of B-cell lymphoma[ J]. Cancer, 1983,52(8) :141.
6Jaffe ES, Harris NL, Diebold J, et al. World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissue. A prog ressreport[J]. Am J Clin Pathol, 1999,111 ( 1 ) :58.
7Harris NL,Jaffe ES,Disbold J,et al. The World Health Organization classification of hematological malignancies repor of the clinical aelvisory committee meeting, Airlie horse, Virginia[J]. Mod Pathol,2000, 13(2):19.
8Lehours P, Megraud F. Helicobacter pylori infection and gastric MALT lymphoma[ J]. Rocz Akad Med Bialymst ,2005,50( 1 ) :54 - 61.
9Fischbach W,Goebeler-Kolve ME, Dragosics B ,et al. Long term outcome of patients with gastric marginal zone B cell lymphoma mucesa associated lymphoid tissue ( MALT ) following exclusive Hlicobacter pylori eradication therapy:experience from a large prospective series [J]. Gut.2004,53 ( 1 ) :34 -37.
10Zucca E, Bertonl F, Roggero E, et al. Molecular analysis of the progression from Helicobacter pylori-associated chroie gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach[ J]. N Engl J Med,1998,33(8) :804 -810.
